Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments.

Shehata L, Wieland-Alter WF, Maurer DP, Chen E, Connor RI, Wright PF, Walker LM.

Nat Commun. 2019 Mar 8;10(1):1126. doi: 10.1038/s41467-019-09085-1.

2.

Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal diet.

Connor RI, Zain-Ul-Abideen M, Magohe AK, Brickley EB, Housman ML, Lyimo MA, Mchaki B, Maro I, Hendricks KM, Lukmanji Z, Matee M, Bakari M, Pallangyo K, Von Reyn CF.

AIDS. 2019 Mar 1;33(3):509-514. doi: 10.1097/QAD.0000000000002081.

PMID:
30702519
3.

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants.

Brickley EB, Wieland-Alter W, Connor RI, Ackerman ME, Boesch AW, Arita M, Weldon WC, O'Ryan MG, Bandyopadhyay AS, Wright PF.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S42-S50. doi: 10.1093/cid/ciy603.

4.

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Goodwin E, Gilman MSA, Wrapp D, Chen M, Ngwuta JO, Moin SM, Bai P, Sivasubramanian A, Connor RI, Wright PF, Graham BS, McLellan JS, Walker LM.

Immunity. 2018 Feb 20;48(2):339-349.e5. doi: 10.1016/j.immuni.2018.01.005. Epub 2018 Feb 3.

5.

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.

Brickley EB, Strauch CB, Wieland-Alter WF, Connor RI, Lin S, Weiner JA, Ackerman ME, Arita M, Oberste MS, Weldon WC, Sáez-Llorens X, Bandyopadhyay AS, Wright PF.

J Infect Dis. 2018 Jan 17;217(3):371-380. doi: 10.1093/infdis/jix556.

6.

Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.

von Reyn CF, Lahey T, Arbeit RD, Landry B, Kailani L, Adams LV, Haynes BC, Mackenzie T, Wieland-Alter W, Connor RI, Tvaroha S, Hokey DA, Ginsberg AM, Waddell R.

PLoS One. 2017 May 12;12(5):e0175215. doi: 10.1371/journal.pone.0175215. eCollection 2017.

7.

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.

Wright PF, Connor RI, Wieland-Alter WF, Hoen AG, Boesch AW, Ackerman ME, Oberste MS, Gast C, Brickley EB, Asturias EJ, Rüttimann R, Bandyopadhyay AS.

Lancet Infect Dis. 2016 Dec;16(12):1377-1384. doi: 10.1016/S1473-3099(16)30169-4. Epub 2016 Sep 13.

8.

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine.

Wright PF, Hoen AG, Ilyushina NA, Brown EP, Ackerman ME, Wieland-Alter W, Connor RI, Jegaskanda S, Rosenberg-Hasson Y, Haynes BC, Luke CJ, Subbarao K, Treanor JJ.

Open Forum Infect Dis. 2016 May 23;3(2):ofw108. doi: 10.1093/ofid/ofw108. eCollection 2016 Apr.

9.
10.

Breast milk from Tanzanian women has divergent effects on cell-free and cell-associated HIV-1 infection in vitro.

Lyimo MA, Mosi MN, Housman ML, Zain-Ul-Abideen M, Lee FV, Howell AL, Connor RI.

PLoS One. 2012;7(8):e43815. doi: 10.1371/journal.pone.0043815. Epub 2012 Aug 28.

11.

Characterization of Lactobacillus salivarius CECT 5713, a strain isolated from human milk: from genotype to phenotype.

Langa S, Maldonado-Barragán A, Delgado S, Martín R, Martín V, Jiménez E, Ruíz-Barba JL, Mayo B, Connor RI, Suárez JE, Rodríguez JM.

Appl Microbiol Biotechnol. 2012 Jun;94(5):1279-87. doi: 10.1007/s00253-012-4032-1. Epub 2012 Apr 19.

PMID:
22526789
12.

Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus.

Wira CR, Ghosh M, Smith JM, Shen L, Connor RI, Sundstrom P, Frechette GM, Hill ET, Fahey JV.

Mucosal Immunol. 2011 May;4(3):335-42. doi: 10.1038/mi.2010.72. Epub 2010 Nov 3.

13.

Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes.

Dorosko SM, Connor RI.

J Virol. 2010 Oct;84(20):10533-42. doi: 10.1128/JVI.01263-10. Epub 2010 Aug 11.

14.

Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk.

Martín V, Maldonado A, Fernández L, Rodríguez JM, Connor RI.

Breastfeed Med. 2010 Aug;5(4):153-8. doi: 10.1089/bfm.2010.0001.

15.

Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-associated HIV-1 infection of CD4+ cells.

Lyimo MA, Howell AL, Balandya E, Eszterhas SK, Connor RI.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):117-24. doi: 10.1097/QAI.0b013e3181a3908d.

PMID:
19346967
16.

Induction of HIV-1 MPR(649-684)-specific IgA and IgG antibodies in caprine colostrum using a peptide-based vaccine.

Dorosko SM, Ayres SL, Connor RI.

Vaccine. 2008 Oct 3;26(42):5416-22. doi: 10.1016/j.vaccine.2008.07.079. Epub 2008 Aug 15.

PMID:
18708113
17.

Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed.

Dorosko SM, Mackenzie T, Connor RI.

Breastfeed Med. 2008 Jun;3(2):117-9. doi: 10.1089/bfm.2007.0036.

PMID:
18564000
18.

Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

Metzner KJ, Binley JM, Gettie A, Marx P, Nixon DF, Connor RI.

Retrovirology. 2006 Dec 21;3:97.

19.

Sensitivity of non-clade B primary HIV-1 isolates to mildly acidic pH.

Connor RI.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):499-501. No abstract available.

PMID:
17099316
20.

Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.

Metzner KJ, Moretto WJ, Donahoe SM, Jin X, Gettie A, Montefiori DC, Marx PA, Binley JM, Nixon DF, Connor RI.

J Gen Virol. 2005 Dec;86(Pt 12):3375-84.

PMID:
16298985
21.

A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication.

Chakrabarti LA, Metzner KJ, Ivanovic T, Cheng H, Louis-Virelizier J, Connor RI, Cheng-Mayer C.

J Virol. 2003 Jan;77(2):1245-56.

22.

Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.

Donahoe SM, Moretto WJ, Samuel RV, Metzner KJ, Marx PA, Hanke T, Connor RI, Nixon DF.

Virology. 2000 Jul 5;272(2):347-56.

23.

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

Metzner KJ, Jin X, Lee FV, Gettie A, Bauer DE, Di Mascio M, Perelson AS, Marx PA, Ho DD, Kostrikis LG, Connor RI.

J Exp Med. 2000 Jun 5;191(11):1921-31.

24.

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.

Nixon DF, Donahoe SM, Kakimoto WM, Samuel RV, Metzner KJ, Gettie A, Hanke T, Marx PA, Connor RI.

Virology. 2000 Jan 5;266(1):203-10.

25.

Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression.

Smith SM, Holland B, Russo C, Dailey PJ, Marx PA, Connor RI.

AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1691-701.

PMID:
10606092
26.

Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Schramm B, Penn ML, Speck RF, Chan SY, De Clercq E, Schols D, Connor RI, Goldsmith MA.

J Virol. 2000 Jan;74(1):184-92.

28.

CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.

Mariani R, Wong S, Mulder LC, Wilkinson DA, Reinhart AL, LaRosa G, Nibbs R, O'Brien TR, Michael NL, Connor RI, Macdonald M, Busch M, Koup RA, Landau NR.

J Virol. 1999 Mar;73(3):2450-9.

29.

Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

Connor RI, Montefiori DC, Binley JM, Moore JP, Bonhoeffer S, Gettie A, Fenamore EA, Sheridan KE, Ho DD, Dailey PJ, Marx PA.

J Virol. 1998 Sep;72(9):7501-9.

30.

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.

Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE.

J Infect Dis. 1998 Feb;177(2):310-9.

PMID:
9466516
31.

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, McDonald D, McWilliams N, Trkola A, Moore JP, Wolinsky SM.

J Virol. 1998 Feb;72(2):1552-76.

32.

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR.

J Exp Med. 1997 Feb 17;185(4):621-8.

34.
35.
36.
37.
39.

Transmission and pathogenesis of human immunodeficiency virus type 1.

Connor RI, Ho DD.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):321-3. Review. No abstract available.

PMID:
8068409
41.

Biological cloning of functionally diverse quasispecies of HIV-1.

Connor RI, Notermans DW, Mohri H, Cao Y, Ho DD.

AIDS Res Hum Retroviruses. 1993 Jun;9(6):541-6.

PMID:
8347398
42.
45.

1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1.

Connor RI, Rigby WF.

Biochem Biophys Res Commun. 1991 Apr 30;176(2):852-9.

PMID:
1673842
47.

Supplemental Content

Loading ...
Support Center